Find your next paid study

Actual pay is set by the research site.

Martin PiazzaNCT07516067

Skin Laxity (Submental and Neck)Facial Skin LaxitySubmental Tissue Laxity

A Prospective, Multi-center, Randomized Controlled, Non-inferiority Study to Evaluate the Safety and Effectiveness of ULTRAFORMER MPT PLUS Treatment to Lift Lax Submental (Beneath the Chin) and Neck Tissue

This is a prospective, multicenter, randomized, evaluator-blinded, parallel-controlled, non-inferiority clinical study designed to evaluate the safety and effe…

~$10 – $1,050

Actual pay is set by the research site.

CLASSYS Inc.NCT07229430

Phase 2

NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy

To learn if psilocybin can help to prevent or decrease the severity of chemotherapy-induced peripheral neuropathy (CIPN) in patients who are receiving chemothe…

PsilocybinNeuropathy

M.D. Anderson Cancer CenterNCT07227909

~$75 – $2,000

Actual pay is set by the research site.

CGM- and Behavior-based Large Health Model for Just-in-time Diabetes Management

The primary objective of this research, funded by Samsung Strategic Alliance for Research and Technology, is to develop multi-modal foundation models that inte…

Type 2 Diabetes

Johns Hopkins UniversityNCT07633171

Actual pay is set by the research site.

Phase 3

A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Flexible-adaptive, Group Sequential Study to Evaluate the Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, flexible-adaptive, group-sequential study (Part A), followed by an open-la…

Sickle Cell Disease

~$50 – $2,250

Actual pay is set by the research site.

SanofiNCT06975865

A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Evaluating the Efficacy of Multiple Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Treatment of Nonhealing Diabetic Foot Ulcers.

The goal of this clinical trial is to learn if using perinatal tissue allografts improves healing of chronic, non-healing foot ulcers in diabetic patients. Th…

Diabetic Foot Ulcer

Samaritan BiologicsNCT06437028

Actual pay is set by the research site.

Readiness Outcomes Affecting Return to Sport 3.0

The primary aim is to determine if MST will improve coping skills in young athletes returning to sport after ACLR as measured by ACSI-28. Participants will und…

ACL Reconstruction

Boston Children's HospitalNCT07476430

Actual pay is set by the research site.

Suicide, AttemptedSuicidal IdeationDepression

WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt

The goal of this project is to test whether WellPATH-PREVENT (a novel, mobile psychosocial intervention) improves a specific aspect of emotion regulation, i.e.…

Weill Medical College of Cornell UniversityNCT05183230

Actual pay is set by the research site.

Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Serv…

Gastrointestinal NeoplasmsBenign Neoplasm of Intestinal Tract

California Pacific Medical Center Research InstituteNCT01750619

Actual pay is set by the research site.

BRCA1/2-Associated Hereditary Breast and Ovarian Cancer SyndromeBreast Ductal Carcinoma In SituHematopoietic and Lymphoid System Neoplasm+3 more

Approaches to Identify and Care for Individuals With Inherited Cancer Syndromes

This trial examines approaches to identify and care for individuals with inherited cancer syndrome. The purpose of this study is to offer no cost genetic testi…

OHSU Knight Cancer InstituteNCT04494945

Actual pay is set by the research site.

Phase 4

ELRANATAMAB POST TRIAL ACCESS: AN OPEN-LABEL, SINGLE-ARM STUDY FOR PARTICIPANTS WITH MULTIPLE MYELOMA CONTINUING FROM PFIZER-SPONSORED ELRANATAMAB CLINICAL STUDIES

This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical benefit from elranatamab monoth…

Multiple Myeloma

~$25 – $1,500

Actual pay is set by the research site.

PfizerNCT06057402

Diabetic Peripheral Neuropathy

Walking Function in Individuals With Diabetic Peripheral Neuropathy: Biomechanical Mechanisms and Implications for Clinical Outcomes and Gait Retraining

The purpose of this study is to 1) examine the differences in walking function and movement patterns between individuals with diabetic peripheral neuropathy an…